Secondary Logo

February 2019 - Volume 29 - Issue 1
pp: 1-108


Basic science


Translational research


Clinical research


Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter study

Drago, Joshua Z.; Lawrence, Donald; Livingstone, Elisabeth; More

Melanoma Research. 29(1):65-69, February 2019.

Epidemiology of melanoma


Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients

Tan, Sally Y.; Najita, Julie; Li, Xiaoxue; More

Melanoma Research. 29(1):70-76, February 2019.


Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitor-refractory, advanced-stage melanoma

Seremet, Teofila; Planken, Simon; Schwarze, Julia K.; More

Melanoma Research. 29(1):85-88, February 2019.

Clonal heterogeneity of melanoma in a paradigmatic case study: future prospects for circulating melanoma cells

Scaini, Maria Chiara; Pigozzo, Jacopo; Pizzi, Marco; More

Melanoma Research. 29(1):89-94, February 2019.